Tarsus Pharmaceuticals Stock

Tarsus Pharmaceuticals Dividend 2024

Tarsus Pharmaceuticals Dividend

0 USD

Tarsus Pharmaceuticals Dividend yield

Ticker

TARS

ISIN

US87650L1035

How much dividend does Tarsus Pharmaceuticals 2024 pay?

According to the latest status from November 2024, Tarsus Pharmaceuticals paid a total of 0 USD per share in dividends within the last 12 months. With the current Tarsus Pharmaceuticals price of 49.42 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Tarsus Pharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Tarsus Pharmaceuticals Dividend Safe?

Tarsus Pharmaceuticals has been increasing the dividend for 0 years.

Over the past 6 years, Tarsus Pharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Tarsus Pharmaceuticals's Dividend Distributions

Tarsus Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Tarsus Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Tarsus Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Tarsus Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Tarsus Pharmaceuticals Aktienanalyse

What does Tarsus Pharmaceuticals do?

Tarsus Pharmaceuticals Inc is an emerging pharmaceutical company specializing in the development of novel therapies for eye diseases. The company was founded in 2016 and is headquartered in Irvine, California. Tarsus focuses on identifying groundbreaking innovative technologies and drugs for the treatment of eye diseases. Tarsus's business model is based on the idea that there are still no effective treatment methods for many eye diseases. For this reason, the company invests in research and development to close this gap and give affected patients new hope. Tarsus's goal is to improve eye health through the development of drugs and therapies. Tarsus is divided into several divisions that focus on different areas of ophthalmology. These include the development of drugs for the treatment of dry eyes, eyelid twitching, age-related macular degeneration, and other eye diseases. Tarsus's first product, TP-03, is a medication for the treatment of conjunctivitis caused by the bacterium Demodex. This condition affects millions of people worldwide and is often difficult to treat. TP-03 is a novel medication specifically targeting Demodex, thus providing an effective treatment option. Another product from Tarsus is TP-04, a medication for the treatment of dry eyes. This condition is one of the most common eye diseases worldwide, affecting millions of people. TP-04 aims to combat the causes of dry eyes and alleviate the symptoms. Tarsus also has a promising pipeline of products in various stages of development. These include medications for age-related macular degeneration, eyelid twitching, and other eye diseases. Tarsus has entered into partnerships with major pharmaceutical companies and research institutions. These partnerships allow the company to bring its products to market faster and reach a larger audience. Overall, Tarsus has the potential to revolutionize ophthalmology and improve the treatment of many eye diseases. The company has a dedicated team of researchers and scientists who are committed to advancing the development of new therapies and medications. Tarsus Pharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Tarsus Pharmaceuticals stock

How much dividend does Tarsus Pharmaceuticals pay?

Over the past 12 months, Tarsus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tarsus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Tarsus Pharmaceuticals?

The current dividend yield of Tarsus Pharmaceuticals is .

When does Tarsus Pharmaceuticals pay dividends?

Tarsus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Tarsus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tarsus Pharmaceuticals located?

Tarsus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tarsus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tarsus Pharmaceuticals from 11/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.

When did Tarsus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/9/2024.

What was the dividend of Tarsus Pharmaceuticals in the year 2023?

In the year 2023, Tarsus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Tarsus Pharmaceuticals pay out the dividend?

The dividends of Tarsus Pharmaceuticals are distributed in USD.

Andere Kennzahlen von Tarsus Pharmaceuticals

Our stock analysis for Tarsus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tarsus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.